Publications, Pharmaceutical

Improving Intranasal Sprays for Respiratory Viral Infections

Intranasal sprays have considerable potential for the treatment of viral infections such as the SARS-CoV-2 virus which enter via the upper airway.

This paper describes work to improve the targeting of drug delivery for such infections by modifying intranasal spray usage protocols. Computational fluid dynamic studies and experimental validation work show that with an improved protocol, involving more shallowed (almost horizontal) angling of the intranasal spray, drug delivery to the nasopharyngeal viral infection ‘hot spot’ can be doubled. The optimal droplet size for drug delivery for such applications is discussed, and the robustness of the developed protocol is highlighted, with respect to the consistency of drug delivery.

Download Publication
28 Jan 2022

Learn more about Aptar Pharma Expertise
in Nasal Drug Delivery

Find Out More

This Might Also Be of Interest

3 Jul 2023

Intranasal Vaccination: Rationale, Progress and Challenges

Publications, Pharmaceutical, Product Solutions, Device Innovations, Brand Differentiation, Market Insights

Read More
3 Jul 2023

Exploring a Novel Device for Nasal Drug Delivery to the Olfactory System

Publications, Pharmaceutical, Device Innovations, Brand Differentiation, Market Insights, Product Solutions

Read More
15 Jun 2023

Intranasal Delivery of Thin-Film Freeze-Dried Vaccine Powders

Publications, Pharmaceutical, Product Solutions, Device Innovations

Read More
25 May 2023

Exploring the Benefits and Future Possibilities of Nasal Drug Delivery and Drug Repos...

Webinars, Pharmaceutical, Product Solutions, Device Innovations, Brand Differentiation, Market Insights

Read More
1 2 3 4 22
Back To Top